Vikram Thermo (India) Past Earnings Performance
Past criteria checks 1/6
Vikram Thermo (India) has been growing earnings at an average annual rate of 13.7%, while the Pharmaceuticals industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 18.6% per year. Vikram Thermo (India)'s return on equity is 5.3%, and it has net margins of 3.9%.
Key information
13.7%
Earnings growth rate
13.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 18.6% |
| Return on equity | 5.3% |
| Net Margin | 3.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Vikram Thermo (India) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,417 | 56 | 113 | 0 |
| 30 Jun 24 | 1,358 | 41 | 108 | 0 |
| 31 Mar 24 | 1,264 | 254 | 102 | 0 |
| 31 Dec 23 | 1,252 | 244 | 102 | 0 |
| 30 Sep 23 | 1,207 | 212 | 121 | 0 |
| 30 Jun 23 | 1,159 | 183 | 116 | 0 |
| 31 Mar 23 | 1,115 | 169 | 117 | 0 |
| 31 Dec 22 | 1,067 | 155 | 103 | 0 |
| 30 Sep 22 | 984 | 137 | 85 | 0 |
| 30 Jun 22 | 909 | 97 | 83 | 0 |
| 31 Mar 22 | 926 | 87 | 82 | 0 |
| 31 Dec 21 | 849 | 76 | 83 | 0 |
| 30 Sep 21 | 854 | 86 | 78 | 0 |
| 30 Jun 21 | 794 | 105 | 75 | 0 |
| 31 Mar 21 | 736 | 121 | 72 | 0 |
| 31 Dec 20 | 693 | 121 | 64 | 0 |
| 30 Sep 20 | 626 | 108 | 62 | 0 |
| 30 Jun 20 | 628 | 104 | 60 | 0 |
| 31 Mar 20 | 559 | 72 | 59 | 0 |
| 31 Dec 19 | 592 | 82 | 58 | 0 |
| 30 Sep 19 | 606 | 75 | 57 | 0 |
| 30 Jun 19 | 588 | 53 | 70 | 0 |
| 31 Mar 19 | 582 | 44 | 58 | 0 |
| 31 Mar 18 | 486 | 23 | 59 | 0 |
| 31 Mar 17 | 453 | 47 | 52 | 0 |
| 31 Dec 16 | 418 | 50 | 48 | 0 |
| 30 Sep 16 | 406 | 51 | 45 | 0 |
| 30 Jun 16 | 397 | 48 | 42 | 0 |
| 31 Mar 16 | 384 | 42 | 42 | 0 |
| 31 Dec 15 | 373 | 33 | 62 | 0 |
| 30 Sep 15 | 355 | 27 | 60 | 0 |
| 30 Jun 15 | 366 | 29 | 60 | 0 |
| 31 Mar 15 | 372 | 31 | 37 | 0 |
| 31 Dec 14 | 387 | 37 | 60 | 0 |
| 30 Sep 14 | 424 | 42 | 60 | 0 |
| 30 Jun 14 | 419 | 46 | 35 | 0 |
| 31 Mar 14 | 433 | 57 | 58 | 0 |
| 31 Dec 13 | 441 | 70 | 67 | 0 |
Quality Earnings: 530477 has a large one-off loss of ₹243.3M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 530477's current net profit margins (3.9%) are lower than last year (17.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 530477's earnings have grown by 13.7% per year over the past 5 years.
Accelerating Growth: 530477's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 530477 had negative earnings growth (-73.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (20.5%).
Return on Equity
High ROE: 530477's Return on Equity (5.3%) is considered low.